ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.09
0.20 (10.58%)
At close: May 08, 2025, 3:59 PM
2.10
0.48%
After-hours: May 08, 2025, 07:57 PM EDT
10.58% (1D)
| Bid | 2.07 |
| Market Cap | 1.84B |
| Revenue (ttm) | 14.74M |
| Net Income (ttm) | -413.56M |
| EPS (ttm) | -0.62 |
| PE Ratio (ttm) | -3.37 |
| Forward PE | -5.39 |
| Analyst | Buy |
| Ask | 2.16 |
| Volume | 17,219,197 |
| Avg. Volume (20D) | 7,062,895 |
| Open | 1.98 |
| Previous Close | 1.89 |
| Day's Range | 1.91 - 2.17 |
| 52-Week Range | 1.83 - 9.16 |
| Beta | -0.10 |
About IBRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IBRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IBRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
ImmunityBio Inc. is scheduled to release its earnings on May 20, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 days ago
-17.32%
ImmunityBio shares are trading lower after the com...
Unlock content with
Pro Subscription
2 months ago
-13.37%
ImmunityBio shares are trading lower after the company reported worse-than-expected Q4 revenue results.
